Richard I. Steinhart, Director at Actinium Pharmaceuticals, Inc. (ATNM), bought 2,500 shares at $2.01 ($5K) on 2016-04-14, disclosed to the SEC on 2016-04-18.
Open-market purchase of $5k ATNM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BTAI | SELL | 2024-10-03 | $4K | — | Filing → |
| BTAI | SELL | 2024-09-17 | $246 | — | Filing → |
| BTAI | SELL | 2024-06-18 | $469 | — | Filing → |